3 Takeaways From ADA
Tandem Diabetes Care announced that its t:slim X2 and Mobi automated insulin delivery (AID) systems have received a European CE mark, expanding the label to include people with Type 2 diabetes and pregnant individuals with Type 1 diabetes. The approval follows a Circuit trial published in JAMA that showed a 12.6% increase in time‑in‑range for pregnant users, and a New England Journal of Medicine study demonstrating greater A1C reductions in over 300 Type 2 participants. At the same ADA conference, Insulet presented data on its next‑generation Omnipod 6 pump, which delivered 77% time‑in‑range, and previewed an AID system designed to skip mealtime boluses for Type 2 patients. Dexcom also reported that its G7 continuous glucose monitor lowered A1C by 1.6% in non‑insulin‑using Type 2 patients, suggesting a broader role for CGM in diabetes management.
Olympus’ Keith Boettiger on Robotic GI Surgery Push
Olympus, the world’s largest endoscopy system provider, is expanding into robotic gastrointestinal surgery through its Swan Endosurgical platform and a distribution partnership with EndoRobotics. The company aims to democratize complex procedures such as endoscopic submucosal dissection (ESD) by integrating robotics...
Dexcom Buys Nutrisense; Insulet Rolls Out Patch Pump Update
Dexcom announced it has acquired Nutrisense, a wellness app that leverages its over‑the‑counter Stelo continuous glucose monitor to deliver nutrition coaching, though financial terms were not disclosed. The company also unveiled an upcoming Stelo app update that adds AI‑driven pattern‑recognition,...
Medtronic Seeks Clearance for Hugo Surgical Robot in More Indications
Medtronic announced it has submitted 510(k) applications to expand its Hugo surgical robot into general and gynecologic procedures, adding to the urology clearance it received last year. The new indications would cover the majority of surgeries currently performed with Intuitive’s...
Edwards Gets FDA Approval for Surgical Tricuspid Valve
Edwards Lifesciences received FDA clearance for Triformis Resilia, the first surgical valve specifically engineered for tricuspid valve disease. The device uses Edwards' Resilia tissue and a flattened sewing ring that mirrors the native annulus, offering a new surgical option in a...
Medtronic Boosts Revenue by Nearly Double Digits in Q4
Medtronic reported FY26 fourth‑quarter revenue of $9.8 billion, a near‑10% year‑over‑year increase, driving an 8.4% rise in full‑year revenue to $36.36 billion – its strongest top‑line growth in a decade. The surge was powered by the cardiovascular segment, especially cardiac ablation solutions,...
Resmed Completes $340M Noctrix Takeover
ResMed closed a $340 million acquisition of Noctrix Health, adding the FDA‑cleared Nidra device that non‑invasively stimulates nerves to treat restless‑legs syndrome (RLS). Noctrix, which runs about $24 million in annual revenue, brings higher gross margins and a physician‑focused sales channel. ResMed...
Intuitive Elevates Taylor Patton to Chief Commercial and Marketing Officer
Intuitive Surgical promoted veteran executive Taylor Patton to chief commercial and marketing officer effective July 1, succeeding Henry Charlton. Patton, who previously led the endoluminal business and launched the Ion lung‑biopsy robot, will oversee global commercial expansion as competition in robotic...
Natera’s Solomon Moshkevich on How MRD Testing Pinpoints Cancer Recurrence
Natera’s Signatera molecular residual disease (MRD) test analyzes circulating tumor DNA to detect cancer recurrence earlier than traditional imaging or biopsies. Launched in 2019, the test has driven strong revenue growth and is now covered by Medicare for several solid‑tumor...
J&J Recalls Impella Heart Pumps After Patient Dies
Johnson & Johnson’s Abiomed unit recalled seven Impella CP Sets with SmartAssist after an internal review linked the devices to low purge pressure events that caused one patient death and three pump exchanges. The defect appeared in just 0.01 % of over...
Ōura to Add Blood Pressure Feature Following FDA Policy Change
Ōura introduced the Ring 5 smart ring and announced a suite of new health features to roll out in June. The updates include nighttime blood‑pressure trend monitoring, which reports pressure patterns without systolic/diastolic numbers, and a 30‑day view of breathing regularity....
Siemens Healthineers, AiM Team up; Procept Completes Study Enrollment
Siemens Healthineers and AiM Medical Robotics announced a collaboration to integrate AiM’s portable robotic neurosurgery platform with Siemens’ Magnetom MRI scanners, enabling MRI‑guided procedures such as deep‑brain stimulation and tumor ablation. AiM, which raised $8.1 million in a Series A round last...
Abbott Receives CE Mark for Dual Glucose-Ketone Sensor
Abbott has secured the European CE mark for Libre Duo, the first continuous sensor that measures both glucose and ketones. The system will debut in Europe this year with a 15‑day adult version and a 10‑day pediatric version for users as...
Ōura Files for IPO Amid Healthcare Push
Finnish wearables maker Oura has confidentially filed a draft registration statement to launch an initial public offering. The filing follows a $900 million funding round that was earmarked for expanding health‑monitoring capabilities. Oura recently secured FDA clearance to study blood‑pressure detection...
Beta Bionics to Launch Its First Insulin Patch Pump to Compete with Insulet
Beta Bionics announced it will debut its first insulin patch pump, called Mint, by the end of Q2 2027 pending FDA clearance. The three‑day wearable features a 200‑unit reservoir and blends reusable and disposable components, linking to the company’s adaptive dosing...